Default company panoramic image
Logo

Xanthostat Diagnostics, Inc.

Our product can save lives by improving diagnosis of sub-arachnoid hemhorrages (SAH) quickly and easily in the hospital ER.

  • Stage Prototype Ready
  • Industry Medical Devices and Equipment
  • Location Cincinnati, OH, USA
  • Currency USD
  • Founded April 2005
  • Employees 0
  • Website xanthostat.com

Company Summary

Xanthostat has developed a product that aids in diagnosing subarachnoid Hemhorrages (SAH). Our product is now ready to submit to the FDA for approvall under the 510(k) process. SAH takes over 30,000 lives annually. The better detection that our medical device provides could greatly reduce the number of misdiagnoses and hence save lives. Our customers are the hospital ER Doctors and Neurosurgeons that handle the SAH cases.

Team

Advisors

  • Default avatar
    Cors & Basset, LLC
    Lawyer
    Unconfirmed
    Default avatar
    Alex & Company
    Accountant
    Unconfirmed

Previous Investors

  • Default avatar
    Founders, Family & Friends
    Unconfirmed
    Default avatar
    C. Merk & R. Grant
    Unconfirmed
    Default avatar
    QCA Loan
    Unconfirmed